ENTITY

Proteon Therapeutics (PRTO US)

Health Care • United States

ArTara Therapeutics, Inc. researches and develops pharmaceutical products. The Company produces pharmaceuticals to address the medical needs of patients with lymphatic malformations and vascular diseases. ArTara Therapeutics serves customers worldwide.

Refresh

Focused

No publications yet

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00